Important Notice, Table of Contents, and Definitions [Important Notice](index=2&type=section&id=%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA) The company's board, supervisory board, and senior management guarantee the truthfulness, accuracy, and completeness of the semi-annual report, with all directors attending the review meeting - The company's board of directors, supervisory board, and senior management guarantee the truthfulness, accuracy, and completeness of the semi-annual report, free from false records, misleading statements, or major omissions[5](index=5&type=chunk) - Company head Huang Shaoqun, chief financial officer Zhang Li, and head of accounting department Zhang Li declare that the financial report in this semi-annual report is true, accurate, and complete[5](index=5&type=chunk) - The company plans not to distribute cash dividends, bonus shares, or convert capital reserves into share capital[6](index=6&type=chunk) [Table of Contents](index=3&type=section&id=%E7%9B%AE%E5%BD%95) This section lists the report's nine main chapters and their starting page numbers, covering company operations, finance, governance, and other key information - The report comprises nine main chapters, covering company operations, finance, governance, and other important information[8](index=8&type=chunk) [Definitions](index=5&type=section&id=%E9%87%8A%E4%B9%89) This section defines common terms and company-related entities used in the report, including company names, key subsidiaries, and core product categories - “Company” or “Xilong Scientific” refers to Xilong Scientific Co., Ltd[12](index=12&type=chunk) - “Electronic chemicals” include PCB chemical reagents, ultra-pure chemical reagents, and electroplating solutions, primarily used in PCB manufacturing and large-scale integrated circuits[12](index=12&type=chunk) - “Reporting period” or “this reporting period” refers to January 1, 2025, to June 30, 2025[12](index=12&type=chunk) Company Profile and Key Financial Indicators [Company Profile](index=6&type=section&id=%E4%B8%80%E3%80%81%E5%85%AC%E5%8F%B8%E7%AE%80%E4%BB%8B) Xilong Scientific, stock code 002584, is listed on the Shenzhen Stock Exchange, with Huang Shaoqun as its legal representative and headquarters in Guangzhou - Company stock abbreviation: Xilong Scientific, stock code: **002584**, listing exchange: Shenzhen Stock Exchange[14](index=14&type=chunk) - The company's legal representative is Huang Shaoqun, and its contact address is No. 6 Xinrui Road, Science City, Huangpu District, Guangzhou[14](index=14&type=chunk)[15](index=15&type=chunk) - There were no changes in the company's registered address, office address, website, email, information disclosure, or document storage locations during the reporting period[16](index=16&type=chunk)[17](index=17&type=chunk) [Key Accounting Data and Financial Indicators](index=7&type=section&id=%E5%9B%9B%E3%80%81%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) This reporting period saw a 14.78% decrease in operating revenue, a 276.35% decline in net profit attributable to shareholders, and a significant 1014.61% increase in net cash flow from operating activities Key Accounting Data and Financial Indicators for This Reporting Period | Indicator | This Reporting Period (yuan) | Previous Year Same Period (yuan) | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Operating Revenue | 3,367,786,749.48 | 3,951,836,961.47 | -14.78% | | Net Profit Attributable to Shareholders of Listed Company | -75,317,293.94 | 42,708,618.88 | -276.35% | | Net Profit Attributable to Shareholders of Listed Company After Deducting Non-recurring Gains and Losses | 39,576,034.60 | 41,183,165.39 | -3.90% | | Net Cash Flow from Operating Activities | 165,395,748.46 | 14,838,948.48 | 1,014.61% | | Basic Earnings Per Share (yuan/share) | -0.1287 | 0.07 | -283.86% | | Diluted Earnings Per Share (yuan/share) | -0.1287 | 0.07 | -283.86% | | Weighted Average Return on Net Assets | -3.33% | 1.86% | -5.19% | | **Period-end Indicators** | **End of This Reporting Period (yuan)** | **End of Previous Year (yuan)** | **Change from End of Previous Year to End of This Reporting Period** | | Total Assets | 5,009,083,141.89 | 4,715,579,071.58 | 6.22% | | Net Assets Attributable to Shareholders of Listed Company | 2,222,371,296.76 | 2,299,758,397.29 | -3.37% | [Differences in Accounting Data Under Domestic and International Accounting Standards](index=7&type=section&id=%E4%BA%94%E3%80%81%E5%A2%83%E5%86%85%E5%A4%96%E4%BC%9A%E8%AE%A1%E5%87%86%E5%88%99%E4%B8%8B%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%B7%AE%E5%BC%82) The company reported no differences in net profit and net assets between financial statements prepared under Chinese accounting standards and those under international or foreign accounting standards - The company reported no differences in net profit and net assets between financial statements disclosed under International Accounting Standards and Chinese Accounting Standards during the reporting period[20](index=20&type=chunk) - The company reported no differences in net profit and net assets between financial statements disclosed under foreign accounting standards and Chinese Accounting Standards during the reporting period[21](index=21&type=chunk) [Non-recurring Gains and Losses Items and Amounts](index=7&type=section&id=%E5%85%AD%E3%80%81%E9%9D%9E%E7%BB%8F%E5%B8%B8%E6%80%A7%E6%8D%9F%E7%9B%8A%E9%A1%B9%E7%9B%AE%E5%8F%8A%E9%87%91%E9%A2%9D) Total non-recurring gains and losses for this period amounted to **-114.89 million yuan**, primarily due to a significant increase in non-operating expenses from the provision for performance compensation Non-recurring Gains and Losses Items and Amounts | Item | Amount (yuan) | Explanation | | :--- | :--- | :--- | | Gains and Losses from Disposal of Non-current Assets | -13,990.62 | | | Government Subsidies Included in Current Profit and Loss | 1,779,299.53 | | | Other Non-operating Income and Expenses Apart from the Above | -116,271,983.04 | Mainly due to provision for performance compensation of 115.0344 million yuan | | Less: Income Tax Impact | 386,654.41 | | | Total | -114,893,328.54 | | - Non-recurring gains and losses were primarily affected by the provision for performance compensation of **115.0344 million yuan**, leading to a significant increase in non-operating expenses[23](index=23&type=chunk) Management Discussion and Analysis [Main Businesses Engaged by the Company During the Reporting Period](index=9&type=section&id=%E4%B8%80%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E5%85%AC%E5%8F%B8%E4%BB%8E%E4%BA%8B%E7%9A%84%E4%B8%BB%E8%A6%81%E4%B8%9A%E5%8A%A1) The company primarily engages in chemical reagent R&D, production, and sales, along with active pharmaceutical ingredients, food additives, and chemical raw material trade, experiencing revenue decline but growth in new energy business [Industry Development Status of the Company](index=9&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%E6%9C%AC%E5%85%AC%E5%8F%B8%E6%89%80%E5%B1%9E%E8%A1%8C%E4%B8%9A%E5%8F%91%E5%B1%95%E6%83%85%E5%86%B5) The company operates in the chemical raw materials and chemical products manufacturing sector, with chemical reagents playing a crucial role in advanced manufacturing, supported by national policies for localization and breakthroughs - The company's industry belongs to the broad category of “Chemical Raw Materials and Chemical Products Manufacturing”[26](index=26&type=chunk) - Chemical reagents are a vital branch of fine chemicals, providing material foundations and technical support for advanced manufacturing sectors such as microelectronics, new materials, and biomedicine[26](index=26&type=chunk) - National policies strongly support the localization of research reagents and independent breakthroughs in key materials, promoting high-quality industry development[26](index=26&type=chunk) [Overview of Main Businesses and Products During the Reporting Period](index=9&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%E6%8A%A5%E5%91%8A%E6%9C%9F%E4%B8%BB%E8%A6%81%E4%B8%9A%E5%92%8C%E4%BA%A7%E5%93%81%E7%AE%80%E4%BB%8B) The company is a specialized manufacturer and integrated supplier of chemical reagents, with production bases in Foshan, Shantou, Chengdu, and Yunnan Yinghe, offering a diverse product portfolio and a hybrid sales model - The company primarily engages in the R&D, production, and sales of chemical reagents, the production and sales of active pharmaceutical ingredients and food additives, and some chemical raw material trade businesses[27](index=27&type=chunk) - Main products include general chemical reagents, PCB chemical reagents, ultra-pure chemical reagents, photovoltaic and new energy materials (high-purity silver nitrate, silver powder, lithium iron phosphate cathode materials), active pharmaceutical ingredients and pharmaceutical intermediates, and chemical raw materials[29](index=29&type=chunk)[30](index=30&type=chunk) - The company has established a nationwide offline sales and service network and is exploring online sales, having launched the “Youliao.com” trading platform to provide “one-stop procurement for chemical reagents” services[28](index=28&type=chunk) [Key Performance Drivers During the Reporting Period](index=10&type=section&id=%EF%BC%88%E4%B8%89%EF%BC%89%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E4%B8%BB%E8%A6%81%E4%B8%9A%E7%BB%A9%E9%A9%B1%E5%8A%A8%E5%9B%A0%E7%B4%A0) Operating revenue decreased by **14.78%** and net profit attributable to shareholders turned to a loss of **75.32 million yuan**, mainly due to reduced chemical raw material trade and specialized chemical product revenue, alongside a provision for performance compensation, despite stable chemical reagent profitability and rapid growth in new energy business - During the reporting period, the company achieved operating revenue of **3,367.7867 million yuan**, a year-on-year decrease of **14.78%**, primarily due to reduced operating revenue from chemical raw material trade and specialized chemical products[31](index=31&type=chunk) - Net profit attributable to shareholders of the listed company was a loss of **75.3173 million yuan**, a year-on-year decrease of **276.35%**, mainly due to the failure of Shandong Aike Wei Biotechnology Co., Ltd., a subsidiary whose controlling stake was transferred by the company, to meet its performance commitments, leading to the company's provision for estimated liabilities for potential performance compensation obligations[31](index=31&type=chunk) - The company's new energy business revenue grew rapidly, with a significant increase in the production and sales of lithium iron phosphate cathode materials, where monthly production and sales both exceeded **1,000 tons** starting from April 2025[32](index=32&type=chunk)[33](index=33&type=chunk) - The chemical raw material trade segment improved its gross profit margin year-on-year by recognizing revenue on a net basis and adjusting its product structure[33](index=33&type=chunk) [Analysis of Core Competencies](index=11&type=section&id=%E4%BA%8C%E3%80%81%E6%A0%B8%E5%BF%83%E7%AB%9E%E4%BA%89%E5%8A%9B%E5%88%86%E6%9E%90) The company possesses comprehensive service advantages, including one-stop procurement and technical support, leveraging its "specialized, refined, distinctive, and innovative" enterprise status and advanced technological platforms, alongside robust informationization and a nationwide brand and channel network - The company is a specialized manufacturer and integrated supplier of chemical reagents, with over **50,000 SKUs**, capable of providing customers with one-stop services and comprehensive technical support[34](index=34&type=chunk) - The company was selected as a specialized, refined, distinctive, and innovative “Little Giant” enterprise in the fourth batch by the Ministry of Industry and Information Technology, possessing multiple national and provincial-level technological innovation platforms, advanced analytical laboratories, and high-precision testing instruments[34](index=34&type=chunk)[35](index=35&type=chunk) - The company is accelerating its informationization efforts, having built an EHS safety management platform, a marketing management platform, and an integrated digital operation collaboration platform to achieve refined management and control of operational processes[36](index=36&type=chunk)[37](index=37&type=chunk) [Analysis of Main Business](index=12&type=section&id=%E4%B8%89%E3%80%81%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%88%86%E6%9E%90) Operating revenue decreased by **14.78%** due to net method revenue recognition for chemical raw material trade, while operating costs decreased by **15.55%**; net cash flow from operating activities significantly increased by **1014.61%**, and new energy sector revenue grew by **1,855.16%** Year-on-Year Changes in Key Financial Data | Indicator | This Reporting Period (yuan) | Previous Year Same Period (yuan) | Year-on-Year Change | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 3,367,786,749.48 | 3,951,836,961.47 | -14.78% | Starting from 2025, the company participates in bulk chemical raw material trade as an agent, recognizing revenue for this portion of business on a net basis, which led to a decrease in operating revenue compared to the same period last year | | Operating Cost | 3,109,696,109.24 | 3,682,128,176.39 | -15.55% | | | Income Tax Expense | 8,191,948.63 | 5,021,940.02 | 63.12% | Increase in income tax expense accrued this period | | Net Cash Flow from Operating Activities | 165,395,748.46 | 14,838,948.48 | 1,014.61% | Increase in net cash flow from operating activities mainly due to optimized use of operating funds and reduced operating expenses compared to last year | | Net Cash Flow from Investing Activities | -44,897,886.59 | -94,634,932.72 | 52.60% | Decrease in net cash outflow from investing activities mainly due to reduced long-term equity investment expenditures this period | | Net Cash Flow from Financing Activities | -60,403,314.54 | 102,382,501.11 | -159.00% | Net cash outflow from financing activities mainly due to increased cash payments for other financing-related activities this period | | Net Increase in Cash and Cash Equivalents | 60,094,443.28 | 22,597,618.48 | 165.93% | | Operating Revenue Composition (by Industry and Product) | Category | Item | Amount This Reporting Period (yuan) | Proportion of Operating Revenue | Amount Previous Year Same Period (yuan) | Proportion of Operating Revenue | Year-on-Year Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | **By Industry** | Chemical Industry | 3,230,667,576.51 | 95.93% | 3,941,431,216.69 | 99.74% | -18.03% | | | New Energy Industry | 134,016,886.21 | 3.98% | 6,854,508.12 | 0.17% | 1,855.16% | | **By Product** | Electronic Chemicals | 325,325,449.30 | 9.66% | 405,814,016.18 | 10.27% | -19.83% | | | General Reagents | 259,725,863.14 | 7.71% | 306,871,925.44 | 7.77% | -15.36% | | | Chemical Raw Materials | 509,228,770.98 | 15.12% | 826,243,797.78 | 20.91% | -38.37% | | | Specialized Chemicals | 2,108,339,826.26 | 62.60% | 2,329,506,752.20 | 58.95% | -9.49% | | | Lithium Battery Cathode Materials | 134,612,912.47 | 4.00% | 6,857,262.21 | 0.17% | 1,863.07% | | **By Region** | South China Region | 3,029,486,139.14 | 89.95% | 3,660,672,491.98 | 92.63% | -17.24% | | | Southwest Region | 237,224,724.28 | 7.04% | 123,745,937.13 | 3.13% | 91.70% | Industries, Products, or Regions Accounting for Over 10% of Company's Operating Revenue or Operating Profit | Category | Item | Operating Revenue (yuan) | Operating Cost (yuan) | Gross Profit Margin | Operating Revenue Year-on-Year Change | Operating Cost Year-on-Year Change | Gross Profit Margin Year-on-Year Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | **By Industry** | Chemical Industry | 3,230,667,576.50 | 2,963,538,372.98 | 8.27% | -16.02% | -17.02% | 2.22% | | **By Product** | Electronic Chemicals | 325,325,449.30 | 197,183,599.56 | 39.39% | -19.83% | -20.36% | 0.40% | | | Chemical Raw Materials | 509,228,770.98 | 454,592,295.50 | 10.73% | -24.00% | -26.10% | 7.98% | | | Specialized Chemicals | 2,108,339,826.26 | 2,080,691,687.59 | 1.31% | -9.49% | -9.56% | 0.07% | | **By Region** | South China Region | 3,029,486,139.13 | 2,777,867,681.26 | 8.31% | -15.33% | -17.06% | 3.02% | [Analysis of Non-Core Business](index=13&type=section&id=%E5%9B%9B%E3%80%81%E9%9D%9E%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%88%86%E6%9E%90) Non-core business significantly impacted total profit negatively, primarily due to **115.0344 million yuan** in performance compensation provisions, leading to a **-156.57%** increase in non-operating expenses Non-Core Business Analysis | Item | Amount (yuan) | Proportion of Total Profit | Explanation of Cause | | :--- | :--- | :--- | :--- | | Investment Income | -3,460,650.57 | 4.63% | | | Asset Impairment | -12,326,722.54 | 16.50% | | | Non-operating Income | 111,234.93 | -0.15% | | | Non-operating Expenses | 116,976,204.65 | -156.57% | Mainly due to provision for performance compensation of 115.0344 million yuan | - Non-operating expenses were primarily due to the provision for performance compensation of **115.0344 million yuan**, which had a significant negative impact on total profit[46](index=46&type=chunk) [Analysis of Assets and Liabilities](index=14&type=section&id=%E4%BA%94%E3%80%81%E8%B5%84%E4%BA%A7%E5%8F%8A%E8%B4%9F%E5%80%BA%E7%8A%B6%E5%86%B5%E5%88%86%E6%9E%90) Total assets increased by **6.22%** to **5.009 billion yuan**, while net assets attributable to shareholders decreased by **3.37%** to **2.222 billion yuan**, with significant portions of assets restricted due to pledges or collateral Significant Changes in Asset Composition | Item | Amount at End of This Reporting Period (yuan) | Proportion of Total Assets | Amount at End of Previous Year (yuan) | Proportion of Total Assets | Change in Proportion | | :--- | :--- | :--- | :--- | :--- | :--- | | Monetary Funds | 738,401,091.67 | 14.74% | 593,213,839.36 | 12.58% | 2.16% | | Accounts Receivable | 1,494,335,474.70 | 29.83% | 1,359,122,453.22 | 28.82% | 1.01% | | Inventories | 615,340,351.68 | 12.28% | 620,301,753.91 | 13.15% | -0.87% | | Construction in Progress | 30,911,196.97 | 0.62% | 68,235,719.99 | 1.45% | -0.83% | | Short-term Borrowings | 689,245,464.04 | 13.76% | 634,507,374.98 | 13.46% | 0.30% | | Long-term Borrowings | 259,271,042.91 | 5.18% | 272,649,379.82 | 5.78% | -0.60% | Asset Restrictions as of the End of the Reporting Period | Item | Period-end Book Balance (yuan) | Period-end Book Value (yuan) | Reason for Restriction | | :--- | :--- | :--- | :--- | | Monetary Funds | 511,636,697.66 | 511,636,697.66 | Time deposits/Margin deposits/Account freeze | | Other Equity Instrument Investments | 40,152,840.00 | 40,152,840.00 | Pledged for performance commitment fulfillment | | Fixed Assets - Buildings | 65,101,594.78 | 53,992,196.97 | Mortgaged for loans | | Fixed Assets - Production Equipment | 142,807,913 | 65,294,983.72 | Mortgaged for loans | | Intangible Assets - Land | 17,716,000.00 | 16,623,240.91 | Mortgaged for loans | | Total | 740,720,863.63 | 648,683,753.00 | | [Analysis of Investment Status](index=15&type=section&id=%E5%85%AD%E3%80%81%E6%8A%95%E8%B5%84%E7%8A%B6%E5%86%B5%E5%88%86%E6%9E%90) The company's investment amount decreased by **61.00%** year-on-year, with no securities or speculative derivative investments, but **1.1825 million yuan** in hedging-purpose futures derivatives, which generated **26.86 million yuan** in profit, effectively offsetting commodity price volatility Investment Amount During the Reporting Period | Indicator | Amount (yuan) | | :--- | :--- | | Investment Amount This Reporting Period | 25,000,000.00 | | Investment Amount Previous Year Same Period | 64,100,000.00 | | Change Percentage | -61.00% | Derivative Investments for Hedging Purposes | Derivative Investment Type | Period-end Investment Amount (ten thousand yuan) | Proportion of Period-end Investment Amount to Company's Period-end Net Assets | | :--- | :--- | :--- | | Futures | 118.25 | 0.05% | | Total | 118.25 | 0.05% | - During the reporting period, hedging instruments and hedged items collectively generated a profit of **26.86 million yuan**, effectively offsetting price fluctuation risks in spot market transactions[55](index=55&type=chunk) [Major Asset and Equity Sales](index=18&type=section&id=%E4%B8%83%E3%80%81%E9%87%8D%E5%A4%A7%E8%B5%84%E4%BA%A7%E5%92%8C%E8%82%A1%E6%9D%83%E5%87%BA%E5%94%AE) The company did not engage in any sales of major assets or significant equity during the reporting period - The company did not sell major assets during the reporting period[59](index=59&type=chunk) - The company did not sell major equity during the reporting period[60](index=60&type=chunk) [Analysis of Major Holding and Participating Companies](index=18&type=section&id=%E5%85%AB%E3%80%81%E4%B8%BB%E8%A6%81%E6%8E%A7%E8%82%A1%E5%8F%82%E8%82%A1%E5%85%AC%E5%8F%B8%E5%88%86%E6%9E%90) This section presents financial information for the company's major holding subsidiaries and participating companies significantly impacting net profit, noting that Yunnan Yinghe New Energy Materials Co., Ltd. reported a net loss of **23.089 million yuan** Major Subsidiaries and Participating Companies with Over 10% Impact on Company's Net Profit | Company Name | Company Type | Registered Capital (yuan) | Total Assets (yuan) | Net Assets (yuan) | Operating Revenue (yuan) | Operating Profit (yuan) | Net Profit (yuan) | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Sichuan Xilong Scientific Co., Ltd. | Subsidiary | 50,000,000 | 354,101,189.55 | 113,697,963.49 | 136,409,042.43 | 12,008,157.99 | 10,787,962.78 | | Shanghai Xilong Chemical Co., Ltd. | Subsidiary | 100,000,000 | 402,728,438.58 | 141,732,864.38 | 128,807,778.45 | 12,578,745.11 | 9,385,951.93 | | Yunnan Yinghe New Energy Materials Co., Ltd. | Subsidiary | 200,000,000 | 598,049,364.75 | 154,835,227.70 | 134,017,189.98 | -24,263,743.14 | -23,089,382.82 | | Guangzhou Xilong Fine Chemical Technology Co., Ltd. | Subsidiary | 102,000,000 | 749,616,992.27 | 142,572,368.05 | 585,508,001.30 | 2,117,566.83 | 637,045.15 | | Foshan Xilong Chemical Co., Ltd. | Subsidiary | 250,000,000 | 1,196,288,048.80 | 434,178,964.38 | 719,439,593.95 | 7,867,826.45 | 7,527,658.02 | | Guangdong Xilong Chemical Co., Ltd. | Subsidiary | 250,000,000 | 1,443,118,243.74 | 253,610,893.82 | 1,967,518,081.72 | 5,116,643.16 | 3,837,482.93 | - During the reporting period, Yunnan Yinghe New Energy Materials Co., Ltd. reported a net loss of **23,089,382.82 yuan**[61](index=61&type=chunk) [Risks Faced by the Company and Countermeasures](index=19&type=section&id=%E5%8D%81%E3%80%81%E5%85%AC%E5%8F%B8%E9%9D%A2%E4%B8%B4%E7%9A%84%E9%A3%8E%E9%99%A9%E5%92%8C%E5%BA%94%E5%AF%B9%E6%8E%AA%E6%96%BD) The company faces macroeconomic, safety, environmental, R&D, and new business market competition risks, which it addresses through market expansion, internal control, safety investments, continuous innovation, and strategic transformation - The company faces macroeconomic risks, which it addresses by expanding into new markets, increasing market penetration, strengthening internal controls, and reducing costs while increasing efficiency[62](index=62&type=chunk) - Safety production risks are mitigated by intensifying hazard investigations, establishing safety regulations, strengthening training, and adopting advanced equipment[62](index=62&type=chunk) - Technology R&D risks are addressed by increasing R&D investment, attracting talent, fostering industry-academia collaboration, and commercializing intellectual property[63](index=63&type=chunk) - New business market competition risks are managed by leveraging scale, technology, and talent advantages, accelerating transformation and upgrading, innovating market development, implementing refined management, and reducing costs to enhance competitiveness[63](index=63&type=chunk) [Formulation and Implementation of Market Value Management System and Valuation Enhancement Plan](index=19&type=section&id=%E5%8D%81%E4%B8%80%E3%80%81%E5%B8%82%E5%80%BC%E7%AE%A1%E7%90%86%E5%88%B6%E5%BA%A6%E5%92%8C%E4%BC%B0%E5%80%BC%E6%8F%90%E5%8D%87%E8%AE%A1%E5%88%92%E7%9A%84%E5%88%B6%E5%AE%9A%E8%90%BD%E5%AE%9E%E6%83%85%E5%86%B5) The company has not formulated a market value management system nor disclosed any valuation enhancement plans - The company has not formulated a market value management system[64](index=64&type=chunk) - The company has not disclosed a valuation enhancement plan[65](index=65&type=chunk) [Implementation of the 'Dual Improvement in Quality and Returns' Action Plan](index=20&type=section&id=%E5%8D%81%E4%BA%8C%E3%80%81%E2%80%9C%E8%B4%A8%E9%87%8F%E5%9B%9E%E6%8A%A5%E5%8F%8C%E6%8F%90%E5%8D%87%E2%80%9D%E8%A1%8C%E5%8A%A8%E6%96%B9%E6%A1%88%E8%B4%AF%E5%BD%BB%E8%90%BD%E5%AE%9E%E6%83%85%E5%86%B5) The company has not disclosed any announcement regarding the "Dual Improvement in Quality and Returns" action plan - The company has not disclosed an announcement regarding the “Dual Improvement in Quality and Returns” action plan[65](index=65&type=chunk) Corporate Governance, Environment, and Society [Changes in Company Directors, Supervisors, and Senior Management](index=20&type=section&id=%E4%B8%80%E3%80%81%E5%85%AC%E5%8F%B8%E8%91%A3%E4%BA%8B%E3%80%81%E7%9B%91%E4%BA%8B%E3%80%81%E9%AB%98%E7%BA%A7%E7%AE%A1%E7%90%86%E4%BA%BA%E5%91%98%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) There were no changes in the company's directors, supervisors, or senior management during the reporting period - There were no changes in the company's directors, supervisors, or senior management during the reporting period[66](index=66&type=chunk) [Profit Distribution and Capital Reserve Conversion to Share Capital During This Reporting Period](index=20&type=section&id=%E4%BA%8C%E3%80%81%E6%9C%AC%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%88%A9%E6%B6%A6%E5%88%86%E9%85%8D%E5%8F%8A%E8%B5%84%E6%9C%AC%E5%85%AC%E7%A7%AF%E9%87%91%E8%BD%AC%E5%A2%9E%E8%82%A1%E6%9C%AC%E6%83%85%E5%86%B5) The company plans not to distribute cash dividends, bonus shares, or convert capital reserves into share capital for the semi-annual period - The company plans not to distribute cash dividends, bonus shares, or convert capital reserves into share capital for the semi-annual period[67](index=67&type=chunk) [Implementation of Company Equity Incentive Plans, Employee Stock Ownership Plans, or Other Employee Incentive Measures](index=20&type=section&id=%E4%B8%89%E3%80%81%E5%85%AC%E5%8F%B8%E8%82%A1%E6%9D%83%E6%BF%80%E5%8A%B1%E8%AE%A1%E5%88%92%E3%80%81%E5%91%98%E5%B7%A5%E6%8C%81%E8%82%A1%E8%AE%A1%E5%88%92%E6%88%96%E5%85%B6%E4%BB%96%E5%91%98%E5%B7%A5%E6%BF%80%E5%8A%B1%E6%8E%AA%E6%96%BD%E7%9A%84%E5%AE%9E%E6%96%BD%E6%83%85%E5%86%B5) The company had no equity incentive plans, employee stock ownership plans, or other employee incentive measures in place or implemented during the reporting period - The company had no equity incentive plans, employee stock ownership plans, or other employee incentive measures and their implementation during the reporting period[68](index=68&type=chunk) [Environmental Information Disclosure](index=20&type=section&id=%E5%9B%9B%E3%80%81%E7%8E%AF%E5%A2%83%E4%BF%A1%E6%81%AF%E6%8A%AB%E9%9C%B2%E6%83%85%E5%86%B5) Sichuan Xilong Scientific Co., Ltd., a major subsidiary, is listed among enterprises required to disclose environmental information and has done so on the relevant system - Among the listed company and its major subsidiaries, Sichuan Xilong Scientific Co., Ltd. has been included in the list of enterprises required to disclose environmental information by law[69](index=69&type=chunk) - Sichuan Xilong Scientific Co., Ltd.'s legally disclosed environmental information report can be found on the Enterprise Environmental Information Legal Disclosure System (Sichuan)[69](index=69&type=chunk) [Social Responsibility](index=20&type=section&id=%E4%BA%94%E3%80%81%E7%A4%BE%E4%BC%9A%E8%B4%A3%E4%BB%BB%E6%83%85%E5%86%B5) The company actively fulfills its social responsibilities by donating materials to support the "Hundred Counties, Thousand Towns, Ten Thousand Villages High-Quality Development Project" and the "Overseas Chinese Economic and Cultural Cooperation Project" in Shantou - The company actively gives back to society by donating materials for the construction of Shantou's “Hundred Counties, Thousand Towns, Ten Thousand Villages High-Quality Development Project” and the “Overseas Chinese Economic and Cultural Cooperation Project”[70](index=70&type=chunk) Significant Matters [Commitments Fulfilled During the Reporting Period and Overdue Unfulfilled Commitments by the Company's Actual Controllers, Shareholders, Related Parties, Acquirers, and the Company](index=21&type=section&id=%E4%B8%80%E3%80%81%E5%85%AC%E5%8F%B8%E5%AE%9E%E9%99%85%E6%8E%A7%E5%88%B6%E4%BA%BA%E3%80%81%E8%82%A1%E4%B8%9C%E3%80%81%E5%85%B3%E8%81%94%E6%96%B9%E3%80%81%E6%94%B6%E8%B4%AD%E4%BA%BA%E4%BB%A5%E5%8F%8A%E5%85%AC%E5%8F%B8%E7%AD%89%E6%89%BF%E8%AF%BA%E7%9B%B8%E5%85%B3%E6%96%B9%E5%9C%A8%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E5%B1%A5%E8%A1%8C%E5%AE%8C%E6%AF%95%E5%8F%8A%E6%88%AA%E8%87%B3%E6%8A%A5%E5%91%8A%E6%9C%AB%E8%B6%85%E6%9C%9F%E6%9C%AA%E5%B1%A5%E8%A1%8C%E5%AE%8C%E6%AF%95%E7%9A%84%E6%89%BF%E8%AF%BA%E4%BA%8B%E9%A1%B9) During the reporting period, there were no commitments by the company's actual controllers, shareholders, related parties, acquirers, or the company that were either fulfilled or overdue and unfulfilled - During the reporting period, there were no commitments by the company's actual controllers, shareholders, related parties, acquirers, or the company that were either fulfilled or overdue and unfulfilled as of the end of the reporting period[72](index=72&type=chunk) [Non-Operating Fund Occupation by Controlling Shareholders and Other Related Parties of the Listed Company](index=21&type=section&id=%E4%BA%8C%E3%80%81%E6%8E%A7%E8%82%A1%E8%82%A1%E4%B8%9C%E5%8F%8A%E5%85%B6%E4%BB%96%E5%85%B3%E8%81%94%E6%96%B9%E5%AF%B9%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E7%9A%84%E9%9D%9E%E7%BB%8F%E8%90%A5%E6%80%A7%E5%8D%A0%E7%94%A8%E8%B5%84%E9%87%91%E6%83%85%E5%86%B5) During the reporting period, there was no non-operating fund occupation by controlling shareholders or other related parties of the listed company - During the reporting period, there was no non-operating fund occupation by controlling shareholders or other related parties of the listed company[73](index=73&type=chunk) [Illegal External Guarantees](index=21&type=section&id=%E4%B8%89%E3%80%81%E8%BF%9D%E8%A7%84%E5%AF%B9%E5%A4%96%E6%8B%85%E4%BF%9D%E6%83%85%E5%86%B5) The company had no illegal external guarantees during the reporting period - The company had no illegal external guarantees during the reporting period[74](index=74&type=chunk) [Appointment and Dismissal of Accounting Firms](index=21&type=section&id=%E5%9B%9B%E3%80%81%E8%81%98%E4%BB%BB%E3%80%81%E8%A7%A3%E8%81%98%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%83%85%E5%86%B5) The company's semi-annual financial report was not audited - The company's semi-annual report was not audited[75](index=75&type=chunk) [Board of Directors' and Supervisory Board's Explanations on the Accounting Firm's 'Non-Standard Audit Report' for This Reporting Period](index=21&type=section&id=%E4%BA%94%E3%80%81%E8%91%A3%E4%BA%8B%E4%BC%9A%E3%80%81%E7%9B%91%E4%BA%8B%E4%BC%9A%E5%AF%B9%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%9C%AC%E6%8A%A5%E5%91%8A%E6%9C%9F%22%E9%9D%9E%E6%A0%87%E5%87%86%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A%22%E7%9A%84%E8%AF%B4%E6%98%8E) This section is not applicable as the company did not have a non-standard audit report during the reporting period - Not applicable, as the company had no non-standard audit report during the reporting period[76](index=76&type=chunk) [Board of Directors' Explanations on the 'Non-Standard Audit Report' for the Previous Year](index=21&type=section&id=%E5%85%AD%E3%80%81%E8%91%A3%E4%BA%8B%E4%BC%9A%E5%AF%B9%E4%B8%8A%E5%B9%B4%E5%BA%A6%22%E9%9D%9E%E6%A0%87%E5%87%86%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A%22%E7%9B%B8%E5%85%B3%E6%83%85%E5%86%B5%E7%9A%84%E8%AF%B4%E6%98%8E) This section is not applicable as the company did not have a non-standard audit report during the reporting period - Not applicable, as the company had no non-standard audit report during the reporting period[76](index=76&type=chunk) [Bankruptcy and Reorganization Matters](index=21&type=section&id=%E4%B8%83%E3%80%81%E7%A0%B4%E4%BA%A7%E9%87%8D%E6%95%B4%E7%9B%B8%E5%85%B3%E4%BA%8B%E9%A1%B9) The company did not experience any bankruptcy or reorganization matters during the reporting period - The company did not experience any bankruptcy or reorganization matters during the reporting period[76](index=76&type=chunk) [Litigation Matters](index=21&type=section&id=%E5%85%AB%E3%80%81%E8%AF%89%E8%AE%BC%E4%BA%8B%E9%A1%B9) The company is involved in multiple lawsuits, including securities misrepresentation disputes totaling **14.5637 million yuan** (partially settled, some appealed) and **8.041 million yuan** (first instance not yet ruled), with provisions for estimated liabilities made for some cases - Huang Zhi*, Du Gui*, and 111 other investors sued Xilong Scientific for securities misrepresentation liability, involving **14.5637 million yuan**; some cases were settled, while the company has appealed the first-instance judgments for the unsettled portions[78](index=78&type=chunk) - Lin *Zhen, Yang *Feng, and 71 other investors sued Xilong Scientific for securities misrepresentation liability, involving **8.041 million yuan**; the first instance has been heard but not yet ruled[78](index=78&type=chunk) - Other small-amount lawsuits where the company and its subsidiaries are plaintiffs collectively involve **4.1992 million yuan**; some have won in the first instance and applied for enforcement, while others are still in first-instance trial or have not yet been heard[78](index=78&type=chunk) [Penalties and Rectification](index=22&type=section&id=%E4%B9%9D%E3%80%81%E5%A4%84%E7%BD%9A%E5%8F%8A%E6%95%B4%E6%94%B9%E6%83%85%E5%86%B5) The company had no penalties or rectification situations during the reporting period - The company had no penalties or rectification situations during the reporting period[79](index=79&type=chunk) [Integrity Status of the Company, its Controlling Shareholders, and Actual Controllers](index=23&type=section&id=%E5%8D%81%E3%80%81%E5%85%AC%E5%8F%B8%E5%8F%8A%E5%85%B6%E6%8E%A7%E8%82%A1%E8%82%A1%E4%B8%9C%E3%80%81%E5%AE%9E%E9%99%85%E6%8E%A7%E5%88%B6%E4%BA%BA%E7%9A%84%E8%AF%9A%E4%BF%A1%E7%8A%B6%E5%86%B5) There were no issues regarding the integrity status of the company, its controlling shareholders, or actual controllers during the reporting period - There were no issues regarding the integrity status of the company, its controlling shareholders, or actual controllers during the reporting period[80](index=80&type=chunk) [Major Related Party Transactions](index=23&type=section&id=%E5%8D%81%E4%B8%80%E3%80%81%E9%87%8D%E5%A4%A7%E5%85%B3%E8%81%94%E4%BA%A4%E6%98%93) The company did not engage in any major related party transactions during the reporting period, including those related to daily operations, asset/equity acquisitions or disposals, joint external investments, or related party creditor-debtor relationships - The company had no related party transactions related to daily operations during the reporting period[80](index=80&type=chunk) - The company had no related party transactions involving asset or equity acquisitions or disposals during the reporting period[81](index=81&type=chunk) - The company had no related party creditor-debtor relationships during the reporting period[83](index=83&type=chunk) [Major Contracts and Their Fulfillment](index=24&type=section&id=%E5%8D%81%E4%BA%8C%E3%80%81%E9%87%8D%E5%A4%A7%E5%90%88%E5%90%8C%E5%8F%8A%E5%85%B6%E5%B1%A5%E8%A1%8C%E6%83%85%E5%86%B5) The company has no trust or contracting matters but engages in leasing as both lessor (industrial parks) and lessee (warehouses, offices), and provides significant guarantees, primarily to subsidiaries, with a total outstanding guarantee balance of **858.0812 million yuan**, representing **38.61%** of net assets - As a lessor, the company continues to develop industrial park and incubator projects, generating rental income[89](index=89&type=chunk) - As a lessee, the company leases warehouses, office buildings/offices, and employee dormitories, paying rental fees[90](index=90&type=chunk) Total Company Guarantees | Indicator | Amount (ten thousand yuan) | | :--- | :--- | | Total Approved Guarantee Limit During the Reporting Period | 214,000 | | Total Actual Guarantees Issued During the Reporting Period | 121,730.9 | | Total Approved Guarantee Limit at End of Reporting Period | 214,000 | | Total Actual Outstanding Guarantees at End of Reporting Period | 85,808.12 | | Proportion of Total Actual Guarantees to Company's Net Assets | 38.61% | - The company had no entrusted wealth management during the reporting period[97](index=97&type=chunk) - The company had no other major contracts during the reporting period[98](index=98&type=chunk) [Explanation of Other Significant Matters](index=28&type=section&id=%E5%8D%81%E4%B8%89%E3%80%81%E5%85%B6%E4%BB%96%E9%87%8D%E5%A4%A7%E4%BA%8B%E9%A1%B9%E7%9A%84%E8%AF%B4%E6%98%8E) The company disclosed on April 30, 2025, that it expects to incur a **115.0344 million yuan** performance compensation obligation related to the transfer of its controlling stake in Shandong Aike Wei Biotechnology Co., Ltd., for which a provision for estimated liabilities has been made - The company preliminarily estimates it will bear a performance compensation amount of **115.0344 million yuan** for Shandong Aike Wei Biotechnology Co., Ltd.'s performance commitment, and has already made a provision for estimated liabilities[99](index=99&type=chunk) - This compensation obligation is due to Aike Wei Biotechnology's failure to meet its performance commitments for the years 2022-2024[99](index=99&type=chunk) [Significant Matters of Company Subsidiaries](index=28&type=section&id=%E5%8D%81%E5%9B%9B%E3%80%81%E5%85%AC%E5%8F%B8%E5%AD%90%E5%85%AC%E5%8F%B8%E9%87%8D%E5%A4%A7%E4%BA%8B%E9%A1%B9) There were no significant matters concerning the company's subsidiaries during the reporting period - There were no significant matters concerning the company's subsidiaries during the reporting period[100](index=100&type=chunk) Share Changes and Shareholder Information [Share Change Status](index=29&type=section&id=%E4%B8%80%E3%80%81%E8%82%A1%E4%BB%BD%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) During the reporting period, restricted shares decreased by **35,932,481 shares**, while unrestricted shares increased by the same amount, primarily due to the unlocking of shares held by directors and senior management Share Change Status | Share Class | Quantity Before This Change (shares) | Proportion Before This Change | Increase/Decrease in This Change (shares) | Quantity After This Change (shares) | Proportion After This Change | | :--- | :--- | :--- | :--- | :--- | :--- | | I. Restricted Shares | 152,722,376 | 26.10% | -35,932,481 | 116,789,895 | 19.96% | | Of which: Shares held by domestic natural persons | 148,316,023 | 25.34% | -35,932,481 | 112

Meeting Overview - The first extraordinary general meeting of shareholders for 2025 was held on August 13, 2025, at 14:30 [3][4] - The meeting combined on-site voting and online voting methods [5] - The meeting was convened by the company's board of directors [6] Attendance - A total of 704 shareholders attended the meeting, representing 153,932,872 shares, which is 26.3036% of the total voting shares [8] - Among them, 5 shareholders attended in person, representing 149,844,722 shares (25.6050%), while 699 shareholders voted online, representing 4,088,150 shares (0.6986%) [9][10] - 699 minority shareholders participated, representing 4,088,150 shares (0.6986%) [11] Proposal Voting Results - The proposal to amend the company's articles of association was approved with 153,011,872 votes in favor (99.4017%) [13] - The proposal to amend and establish certain governance systems was also approved, with 152,983,872 votes in favor (99.3835%) [15] - The proposal to amend the board meeting rules received 152,974,272 votes in favor (99.3773%) [17] - The proposal to amend the independent director work system was approved with 152,980,072 votes in favor (99.3810%) [20] - The proposal to amend the external guarantee management system was approved with 152,885,572 votes in favor (99.3196%) [22] - The proposal to amend the external investment management system received 152,958,072 votes in favor (99.3667%) [24] - The proposal to amend the related party transaction management system was approved with 152,948,872 votes in favor (99.3608%) [26] - The proposal to amend the special storage and use management system for raised funds received 152,957,272 votes in favor (99.3662%) [29] - The proposal to increase the hedging business quota was approved with 152,965,272 votes in favor (99.3714%) [31] Board Changes - The company announced the resignation of non-independent director Zhao Ye due to internal work adjustments, while he will continue as the company's president [35] - Chen Xianglong was elected as the employee representative director, with a term consistent with the sixth board of directors [36]

（编辑 姚尧） 证券日报网讯 8月13日晚间，西陇科学发布公告称，公司董事会现收到公司非独立董事赵晔先生递交的 书面辞职报告。因公司内部工作调整，赵晔先生申请辞去第六届董事会董事职务及董事会战略委员会委 员职务。赵晔先生辞职后继续担任公司总裁职务，同时在子公司任职。 ...

证券日报网讯 8月13日晚间，西陇科学发布公告称，公司2025年第一次临时股东大会于2025年8月13日 召开，审议通过了《关于修订的议案》等多项议案。 （文章来源：证券日报） ...

证券代码：002584 证券简称：西陇科学 公告编号：2025-040 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重要提示： 一、会议召开的情况 （1）现场会议召开时间：2025 年 8 月 13 日 14:30 开始。 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为： 互联网投票系统进行投票的时间为：2025 年 8 月 13 日上午 9:15 至 15:00。 《深圳证券交易所 股票上市规则》、 《上市公司股东会规则》及《公司章程》等法律、法规及规范性 文件的规定。 二、会议的出席情况 通过现场和网络投票的股东 704 人，代表股份 153,932,872 股，占公司有表决 权股份总数的 26.3036％。 其中：通过现场投票的股东 5 人，代表股份 149,844,722 股，占公司有表决 权股份总数的 25.6050％。 通过网络投票的股东 699 人，代表股份 4,088,150 股，占公司有表决权股份 总数的 0.6986％。 通过现场和网络投票的中小股东 699 人，代表股份 4,088,150 股，占公司有 表决权股份 ...

北京中银律师事务所 关于西陇科学股份有限公司 法律意见书 地址：北京市朝阳区光华路正大中心北塔 11-12 层 网址：www.zhongyinlawyer.com 电话：65876666 法律意见书 北京中银律师事务所 关于西陇科学股份有限公司 致：西陇科学股份有限公司 北京中银律师事务所（以下称"本所"）接受西陇科学股份有限公司（以下简 称"公司"）的委托，根据《中华人民共和国公司法》等法律、行政法规、规范性 文件及《西陇科学股份有限公司章程》（以下简称"《公司章程》"）的有关规定， 就公司 2025 年第一次临时股东大会（以下简称"本次股东大会"）的召集、召开程 序、出席人员及召集人资格、大会表决程序、表决结果等事宜，出具法律意见。 本所及经办律师依据《中华人民共和国证券法》《律师事务所从事证券法律业 务管理办法》和《律师事务所证券法律业务执业规则》等规定及本法律意见出具日 以前已经发生或者存在的事实，严格履行了法定职责，遵循了勤勉尽责和诚实信用 原则，进行了充分的核查验证，保证本法律意见书所认定的事实真实、准确、完整， 所发表的结论性意见合法、准确，不存在虚假记载、误导性陈述或者重大遗漏，并 承担相应法 ...

证券代码：002584 证券简称：西陇科学 公告编号：2025-041 西陇科学股份有限公司 关于董事辞职暨选举职工代表董事的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 西陇科学股份有限公司（以下简称"公司"或"西陇科学"）董事会现收到公司 非独立董事赵晔先生递交的书面辞职报告。因公司内部工作调整，赵晔先生申请 辞去第六届董事会董事职务及董事会战略委员会委员职务。赵晔先生辞职后继续 担任公司总裁职务，同时在子公司任职。根据《公司法》及《公司章程》等有关 规定，赵晔先生的辞职未导致公司董事会成员低于法定最低人数，赵晔先生的辞 职报告自送达董事会之日起生效。截至本公告披露日，赵晔先生未持有公司股份， 不存在应当履行而未履行的承诺事项。 根据《公司法》和《公司章程》等相关规定，公司于 2025 年 8 月 13 日召开 职工代表大会并形成决议，与会职工代表一致同意选举陈祥龙先生（简历详见附 件）为公司第六届董事会职工代表董事，任期与公司第六届董事会任期一致。 陈祥龙先生符合《公司法》《公司章程》有关董事任职的资格和条件。此次 选举产生职工代表董事后，公司董 ...

证券代码：002584 证券简称：西陇科学 公告编号：2025-040 西陇科学股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重要提示： 1、本次股东大会无否决提案的情形。 2、本次股东大会无变更以往股东大会已通过决议的情形。 一、会议召开的情况 1、会议召开时间： （1）现场会议召开时间：2025 年 8 月 13 日 14:30 开始。 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为： 2025 年 8 月 13 日 9:15—9:25,9:30—11:30 和 13:00—15:00；通过深圳证券交易所 互联网投票系统进行投票的时间为：2025 年 8 月 13 日上午 9:15 至 15:00。 2、会议召开地点：广州市黄埔区新瑞路 6 号公司 5 楼会议室。 3、会议召开方式：现场投票与网络投票结合的方式召开。 4、会议召集人：公司董事会。 5、会议主持人：董事长黄少群先生。 6、本次股东大会的召集、召开与表决程序符合《公司法》、《深圳证券交易所 股票上市规则》、《上市公司股 ...

北京中银律师事务所 关于西陇科学股份有限公司 2025 年第一次临时股东大会的 法律意见书 地址：北京市朝阳区光华路正大中心北塔 11-12 层 网址：www.zhongyinlawyer.com 电话：65876666 法律意见书 北京中银律师事务所 关于西陇科学股份有限公司 2025 年第一次临时股东大会的法律意见书 致：西陇科学股份有限公司 北京中银律师事务所（以下称"本所"）接受西陇科学股份有限公司（以下简 称"公司"）的委托，根据《中华人民共和国公司法》等法律、行政法规、规范性 文件及《西陇科学股份有限公司章程》（以下简称"《公司章程》"）的有关规定， 就公司 2025 年第一次临时股东大会（以下简称"本次股东大会"）的召集、召开程 序、出席人员及召集人资格、大会表决程序、表决结果等事宜，出具法律意见。 本所及经办律师依据《中华人民共和国证券法》《律师事务所从事证券法律业 务管理办法》和《律师事务所证券法律业务执业规则》等规定及本法律意见出具日 以前已经发生或者存在的事实，严格履行了法定职责，遵循了勤勉尽责和诚实信用 原则，进行了充分的核查验证，保证本法律意见书所认定的事实真实、准确、完整， 所发表 ...

Core Viewpoint - The development of China's chemical reagent industry has evolved from reliance on imports to gradual self-sufficiency, transitioning from low-end general reagents to high-end specialized reagents, with significant growth projected in market size [1][8]. Group 1: Industry Definition and Classification - Chemical reagents are refined fine chemical products derived from industrial-grade chemicals, classified by usage into general chemical reagents, PCB chemical reagents, and ultra-pure reagents, and by purity levels ranging from experimental pure (≥90%) to high purity (≥99.99%) [2][10]. Group 2: Current Development Status - The chemical reagent industry in China has undergone five stages: initial stage, developmental stage, reform and opening-up stage, rapid development stage, and mature development stage, with the current market becoming increasingly competitive [5][7]. Group 3: Market Size and Growth - The market size of China's chemical reagent industry is expected to grow to 240 billion yuan in 2024, an increase of 18.6 billion yuan from 2023, and is projected to reach 260 billion yuan by 2025 [1][8]. Group 4: Industry Chain - The chemical reagent industry is a crucial branch of laboratory supplies and fine chemicals, with the upstream including chemical raw materials, packaging materials, and equipment; the midstream focusing on research and production; and the downstream applications spanning various fields such as pharmaceuticals, new materials, and environmental protection [10][12]. Group 5: Competitive Landscape - The global chemical reagent market is dominated by foreign companies, with major players including Sigma-Aldrich, Thermo Fisher Scientific, and Cayman Chemical, which collectively hold over 80% of the market share in China's research reagent market [14][15]. Group 6: Development Trends - The industry is experiencing transformation driven by technological advancements, with increasing demand for high-performance chemical reagents, particularly in the fields of biotechnology, pharmaceuticals, electronics, and new energy [18][19][20]. - Environmental sustainability is becoming a key trend, prompting the development of green chemical reagents that meet environmental standards [18].